Perspectiva general
Faithful to DIA’s mission of building bridges between the various stakeholders to co-create tangible solutions to the challenges that surround the development of medicinal products, we invite you to join the 2024 DIA Middle East & North Africa (MENA) Conference.
The conference will focus on the unique opportunities and the challenges faced in the MENA region, while exploring innovative solutions. From health authorities to industry leaders, academics and patient representatives, the power of this meeting resides in convening a wide representation of all the stakeholders involved in the medicines’ development lifecycle. The topics of focus will include regional regulatory developments, regulatory strategy, reliance, digitalisation, innovation, and much more.
Collaborate:
Engage with health authorities’ representatives and key Industry leaders from the various countries in the MENA region and contribute to shaping the future of the regulatory landscape in the region.
Connect:
Network with 300 participants, representing a wide aray of countries.
Learn:
Explore new strategies, processes, and collaborative initiatives aimed at creating efficient and sustainable regulatory systems.
Need Approval in Order to Attend?
Download and fill out our Justification Letter to advocate to your supervisor why this is a must-attend event.
Featured
Want to learn more about Middle East and North Africa Conference (MENA)? You've come to the right site!
Comité del programa
-
Amira Younes Director, Global Regulatory Policy EEMEA
MSD, United Arab Emirates -
Anna Litsiou, PhD, MBA, MSc International Regulatory Affairs Policy And Intelligence
AstraZeneca, United Kingdom -
Catherine Al Ashram VP Regulatory Affairs & PV, Latin America MEA and Russia
Organon, Jordan -
Dina Fathy, MPharm, AHIP Senior Director, Regulatory Affairs Middle East Subregional Lead
MSD UAE, United Arab Emirates -
Fadila Lakkis Regulatory Affairs, Intelligence & Communications Manager, Gulf
GSK, United Arab Emirates -
Imane Hattami Therapeutic Area Head and Regulatory Policy Intelligence MEAR
Abbvie Biopharmaceuticals Gmbh, Morocco -
May Shawky Regional Manager Regulatory Affairs MEAR
Merck Group, United Arab Emirates -
Melly Lin, MS CMC Regulatory Policy Lead, Pharma Technical Regulatory
F. Hoffmann-La Roche Ltd, Switzerland -
Niveen Osman, MBA Regulatory Affairs Director Middle East & Africa
Amgen Inc., United Arab Emirates -
Nevena Miletic IFPMA ARN Chair Advisor and Regulatory Policy & Science Chapter Leader
F. Hoffmann-La Roche Ltd, Switzerland -
Sara Torgal, MPharm Senior Manager, Scientific Programs
DIA, Switzerland -
Asmaa Fouad General Manager, Biological and Innovative Products and Clinical Studies
Egyptian Drug Authority , Egypt -
Sondos Moshtohry Manager of the Administration for Cooperation with International Organizations
Egyptian Drug Authority (EDA), Egypt
¿Tiene una cuenta?